Skip to main navigation Skip to search Skip to main content

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (vol 24, pg 282, 2018)

  • Cancer and Leukemia Group B

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)526-526
JournalNature Medicine
Volume24
Issue number4
DOIs
StatePublished - Apr 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

PubMed: MeSH publication types

  • Published Erratum

Cite this